Speaker Profile

Ph.D., Senior Vice President, Research & Development, Castle Biosciences

Bob Cook joined Castle Biosciences in 2011 and currently serves as Senior Vice President, Research & Development. Dr. Cook joined Castle Biosciences following a postdoctoral fellowship at Baylor College of Medicine, where he focused on the genetic regulation of rare ovarian granulosa cell tumors. In his current position, Dr. Cook oversees research and development at Castle. He previously completed his doctoral work in biochemistry, molecular biology and cellular biology at Northwestern University, with a focus on the structural characteristics of protein hormones important for regulating the reproductive system. He received a B.S. degree in molecular biology from Temple University in Philadelphia. Dr. Cook is an author of many medical and scientific publications and a co-inventor of several of Castle Biosciences' technologies.

Improving Patient Care and Outcomes Using Advanced Genomics
Advanced molecular diagnostics are shifting the treatment paradigm for patients with cancers by enabling personalized and risk-aligned disease management decisions. This talk will explore the potential of genomic testing in skin cancers to guide more informed patient care decisions that can improve patient outcomes.

Genomic Profiling Showcase:
Castle Biosciences

Castle Biosciences (Nasdaq: CSTL) is a leading diagnostics company focused on improving health through innovative tests that guide patient care. Castle’s current portfolio consists of tests for skin cancers, uveal melanoma, Barrett’s esophagus and mental health conditions.

 Session Abstract – PMWC 2024 Silicon Valley

Showcase Track S1 - January 24 10.00 A.M.-10.15 A.M.,Showcase Track S1 - January 25 2.30 P.M.-3.00 P.M.,Showcase Track S1 - January 26 9.00 A.M.-9.30 A.M.

The PMWC 2024 Genomic Profiling Showcase will provide a 15 min speaking opportunity for selected companies working with the latest technologies in nucleic acid sequencing such as NGS, providing instrumentation for genomic sequencing, and offering direct to consumer services. These companies will share their innovative products and services to an audience of leading investors, potential clients and partners. The Genomic Profiling Showcase will exhibit the latest innovations in methods and instruments used for DNA/ RNA sequencing to ascertain the genomic and transcriptional profile of a person in order to understand why some people get certain diseases while others do not, or why people react in different ways to the same drug. This information is also being used to develop new ways to diagnose, treat, and prevent diseases, such as cancer.


Add Names/PO on Receipt

Apply to Speak at PMWC Silicon Valley by AUG. 1ST

The PMWC team will reply back to a suitable company/topic with an official request for talk/speaker details.

Contact Us:

Fields marked with an * are required 

Contact Us:

Fields marked with an * are required 

Discover What's Next in Precision Medicine!

Join our community today for the latest news, exclusive interviews, and unique insights from world-renowned speakers and experts

Contact Us:

Fields marked with an * are required 

Discount also depends on group size. The bigger group – the bigger discount.

Trouble Registering

Fields marked with an * are required

Stay Tuned For More Information.

Sign up for occasional updates on upcoming conferences, news, and other information. 

Get Updates:

Submit to Speak in the PMWC Showcase

Fields marked with an * are required